The global healthcare industry is witnessing increasing demand for therapies that address musculoskeletal disorders, chronic pain conditions, and neurological complications. Rising incidences of back pain, sports injuries, arthritis, and spasticity-related disorders are contributing significantly to the adoption of muscle relaxant medications across developed and emerging economies....